Valuation: Pathkey.AI Ltd

Market Cap 4.13Cr 2.89Cr 2.53Cr 2.35Cr 2.16Cr 4.07Cr 278.72Cr 28Cr 11Cr 136.38Cr 11Cr 11Cr 471.13Cr P/E 2024
-1.36x
P/E 2025 -3.77x
Enterprise Value 4.13Cr 2.89Cr 2.53Cr 2.35Cr 2.16Cr 4.07Cr 278.55Cr 28Cr 11Cr 136.3Cr 11Cr 11Cr 470.84Cr EV / Sales 2024
9.78x
EV / Sales 2025 21.1x
Free-Float
59.45%
Yield 2024 *
-
Yield 2025 -
1 day+1.32%
1 week-6.10%
Current month-43.38%
1 month-24.51%
3 months+28.33%
6 months+102.63%
Current year+140.62%
1 week 0.04
Extreme 0.036
0.04
1 month 0.04
Extreme 0.036
0.08
Current year 0.02
Extreme 0.016
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.2
10 years 0.01
Extreme 0.014
3.4
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/01/1994
Chief Executive Officer - 11/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 21/10/2025
Director/Board Member - 21/10/2025
Chairman - 26/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%-6.10%+48.08%-23.00% 1.61Cr
-2.48%-4.71%-35.29%-7.59% 3TCr
-5.97%-15.91%-49.69%+143.22% 1.27TCr
+1.12%-3.61%-24.44%+57.50% 540.81Cr
-4.76%-11.08% - - 208.96Cr
-2.32%-12.73%+44.59%-35.33% 185.83Cr
-3.41%-1.21% - - 178.19Cr
+0.29%-4.92%-36.83% - 105.46Cr
-4.20%-5.04%+37.46%+99.54% 86Cr
-2.10%-6.32%-41.89%-56.65% 75Cr
Average -2.26%-4.37%-7.25%+25.38% 564.67Cr
Weighted average by Cap. -3.01%-3.84%-33.74%+36.40%

Financials

2024 2025
Net sales 4L 3L 2L 2L 2L 4L 2.68Cr 26.96L 10.55L 1.31Cr 10.44L 10.22L 4.54Cr 3L 2L 2L 2L 2L 3L 2.17Cr 21.83L 9L 1.06Cr 8L 8L 3.67Cr
Net income -31.3L -21.9L -19.19L -17.82L -16.37L -30.85L -21Cr -2.12Cr -83.07L -10Cr -82.22L -80.45L -36Cr -14.48L -10.13L -9L -8L -8L -14.27L -9.77Cr -98.16L -38.42L -4.78Cr -38.03L -37.21L -17Cr
Net Debt -4L -3L -2L -2L -2L -4L -2.53Cr -25.4L -10L -1.24Cr -10L -10L -4.28Cr -25.17T -17.61T -15.43T -14.32T -13.16T -24.8T -16.99L -2L -66.78T -8L -66.1T -64.68T -28.72L
Logo Pathkey.AI Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
23/26/23 A$0.0385 +1.32% 4,42,465
22/26/22 A$0.0380 0.00% 6,49,577
21/26/21 A$0.0380 +2.70% 24,13,768
20/26/20 A$0.0370 -5.13% 1,90,562
17/26/17 A$0.0390 -4.88% 36,23,797